BioSpace News Archive

BioNTech SE (Nasdaq: BNTX, “BioNTech”, “the Company”) announced that the Company and the Weizmann Institute of Science (“Weizmann Institute”) signed a Memorandum of Understanding (MoU).

Catalyst Pharmaceuticals, Inc. announced that it will release its fourth quarter and full-year 2022 financial results after the market close on Wednesday, March 15, 2023.

Protara Therapeutics, Inc. today announced that management will participate in the following upcoming investor conferences.

IN8bio, Inc. today announced William Ho, CEO and co-founder, will present a company overview at the Cowen 43rd Annual Healthcare Conference on Tuesday, March 7, 2023 at 12:50 pm ET.

BrainsWay Ltd. today announced that it will report its fourth quarter and full year 2022 financial results as well as operational highlights before the open of the U.S. financial markets on Wednesday, March 15, 2023.

Pliant Therapeutics, Inc. today announced senior management’s participation at the following investor events in March.

Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to solve patients’ problems with current standards of care and provide transformative products to improve their lives, announced today that the management team will participate in the Oppenheimer 33rd Annual Healthcare Conference from March 13th to March 15th.

Keros Therapeutics, Inc. today announced that Keros’ President and Chief Executive Officer Jasbir S. Seehra, Ph.D., will participate in a fireside chat presentation at Cowen’s 43rd Annual Health Care Conference on Wednesday, March 8, 2023 at 11:10 a.m. Eastern time.

Centessa Pharmaceuticals plc today announced the appointment of Patrick Yue, MD, to Centessa’s management team as Senior Vice President of Clinical Development, Innovative Medicines.

PDS Biotechnology Corporation, a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious disease, announced that clinical research conducted by the NCI, one of the Institutes of the National Institutes of Health, was published in the peer-reviewed journal, International Immunopharmacology.